Viewing Study NCT00342108



Ignite Creation Date: 2024-05-05 @ 4:55 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00342108
Status: COMPLETED
Last Update Posted: 2010-11-03
First Post: 2006-06-20

Brief Title: Cortical Visual Impairment and Visual Attentiveness
Sponsor: Sheba Medical Center
Organization: Sheba Medical Center

Study Overview

Official Title: Cortical Visual Impairment and Visual Attentiveness The Effect of Visual and Cross-Modal Environments on Children Diagnosed With Cerebral Palsy and Cortical Visual Impairment
Status: COMPLETED
Status Verified Date: 2010-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will investigate the effect of enhanced visual and cross-modal environments upon the visual attentiveness of multiply handicapped children diagnosed with Cerebral Palsy CP and Cortical Visual Impairment CVI

Research Hypothesis

1 Adapted visual environments which present controlled auditory tactile proprioceptive or contrasting visual background stimulation will enhance the visual attentiveness to a given visual stimulus of children diagnosed with CP and CVI
2 Systematic repetitive visual stimulation over time improves the visual attentiveness andor visual-motor responses of CP-CVI children
3 The analysis of additional behavioral responses to visual stimuli is a critical component in evaluating the perceptual development of visual attention in CP-CVI children

Use of Noldus The Observer an advanced objective computerized observation program will enable precise detection of the neurobehavioral responses of the participants Both overt and covert responses will be observed analyzed and correlated to identify the level of attention of each participant
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None